Ads
related to: cancer drug
Search results
Gilead bets on Xilio cancer drug as biotech restructures
BioPharma Dive via Yahoo Finance· 1 day agoXilio will get just over $40 million from Gilead in return for a license to its experimental IL-12...
Drug could prevent women with ‘Angelina Jolie gene’ developing breast cancer
The Telegraph via Yahoo News· 23 hours agoPrescribing existing drugs to healthy women who carry a gene that makes them more likely to develop...
I faced down drug kingpins. Then cancer came for me.
Tampa Bay Times· 2 hours agoMy life was in danger when I was a federal agent working undercover to bust those who laundered millions of dollars for drug kingpins. It was cancer. My...
Active Cancer Surveillance Doesn't Increase Malpractice Risk
Medscape· 7 hours agoPhysicians should feel reassured in recommending active surveillance as a management strategy for...
The 3 Best Biotech Stocks to Buy in Q2 2024
InvestorPlace· 1 hour agoThe future revenue hinges on successful FDA approvals and the ability to actually sell the drug. If a revolutionary drug gets approved, it can mean loads...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 48 minutes agoAdlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today ...
Can-Fite expands cancer drug rights with Ewopharma By Investing.com
Investing.com· 20 hours agoCan-Fite BioPharma (NYSE:CANF) Ltd. (NYSE American: CANF), a biotechnology firm specializing in...
Improving the world's most potent cancer drug
Medical Xpress· 15 hours agoYou would never guess that, several weeks earlier, half of them had received five times the lethal dose of a leading chemotherapy drug. Doxorubicin (DOX)...
Drugs breakthrough could help those with faulty gene avoid breast cancer surgery
PA Media: Science via Yahoo News· 1 day agoGiving drugs usually administered in the late stages of breast cancer to healthy people with faulty...
Biodexa reports promising brain cancer drug results
Investing.com· 1 day agoBiodexa Pharmaceuticals ( NASDAQ :BDRX), a biopharmaceutical company, has reported promising early trial results for its drug MTX110, aimed at treating...
Ads
related to: cancer drug